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Abstract: The present work was carried out for the production of dipeptidyl peptidase IV (DPP IV; EC 3.4.14.5) using
Aspergillus, Penicillium, and Rhizopus strains under solid state fermentation conditions. Response surface methodology
was applied for the optimization of the selected operational variables (corn flour, initial moisture content, and cultivation
time) for DPP IV activity as the response. The optimal parameters of DPP IV activity for the independent variables,
namely the amount of corn flour (% w/w), initial moisture content (% w/w), and cultivation time (days), were evaluated
to be 2.44%, 60.85%, and 4.69 days, respectively, using Aspergillus awamori T116. The response for these results was also
shown to be in very close agreement with the experimental data.
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Introduction
Studies on the dipeptidyl peptidase IV (DPP IV; EC
3.4.14.5) (CD26) enzyme have focused especially
on human health. Besides being a useful marker for
early diagnosis of diabetic nephropathy and tumor
burden, DPP IV has roles in many biological processes
including pancreatic cancer and rheumatoid arthritis
(1-9). In addition to mammalian cells, DPP IV was
isolated from insect and microbial cells (10). Mentlein
mentioned the interaction of the DPP IV (CD26)
enzyme with mammalian regulatory peptides in detail,
and also mentioned that DPP IV had an important
role not only in the regulation of the endocrine system,
immune system, and gastrointestinal system, but
also in the regulation of the nervous system (11). In
humans, DPP IV was found intensively in kidneys and
small intestine microvilli (12). Insufficient production
of the DPP IV enzyme on the inner surface of the

small intestine results in opioid effects of casomorphin
and gluteomorphin structures, especially in autistics
(13-18). DPP IV is a proline-specific enzyme (19). It
hydrolyzes specifically the X-proline bonds found
in casomorphin and gluteomorphin structures
to overcome the opioid effect (20-22). In autistic
individuals, some other important enzymes of
digestion were also found to be produced insufficiently;
however, the effects of the lack of those enzymes were
not as dramatic as the effects of insufficient DPP
IV (23,24). Although a casein-gluten free diet was
recommended for autistic patients, the effectiveness
of this diet is still under discussion (25-27). Another
approach for the elimination of the opioid effect in
autistics is an enzyme therapy that involves the use
of DPP IV with other digestion enzyme formulations
in capsules prior to, during, or after meals as dietary
supplements (20,22).
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The production of the DPP IV enzyme from
microbial sources has mostly been from fungal
and bacterial origins. Membrane-bound DPP
IV was produced by Lactococcus strains (28,29).
Extracellular DPP IV was isolated and characterized
from Aspergillus oryzae by Tachi et al. (30). Doumas
et al. (31) determined the DPP IV enzyme activity
in the culture medium of Aspergillus oryzae 44 and
TK3 and Aspergillus nidulans. Jalving et al. (32)
cloned the dapB gene from Aspergillus niger and its
nucleotide sequence as well as its protein sequence,
which indicated that the gene encodes DPP IV. Other
studies also reported DPP IV and DPP V gene cloning
and characterization from Aspergillus fumigatus
(33). A search of the databases results in Aspergillus
clavatus NRRL 1 (ACLA_035780) (ACLA_048680),
Aspergillus flavus NRRL 3357 (AFLA_110160)
(AFLA_087160), Aspergillus fumigatus Af293
(NC_007197.1)
(NC_007196.1),
Aspergillus
terreus NIH 2624 (NT_165930.1) (NT_165925.1),
Penicillium marneffei ATCC18224 (PMAA_013400),
and Penicillium chrysogenum Wisconsin 54-1255
(Pc20g06070) for DPP IV gene location and mRNA
information. Production of the DPP IV enzyme from
fungal sources by using submerged fermentation as
well as solid state fermentation (SSF) technologies
is possible. SSF offers well-known advantages over
submerged fermentation, such as higher product
titers, lower waste water output, reduced energy
requirements, and simpler fermentation media.
Hence, since it reflects the natural living conditions
for fungal growth, SSF is mostly used for the
cultivation of fungi.
The present work was focused on fungal sources
and directed toward the production of DPP IV by SSF
where economically feasible and renewable sources
were used as substrates. Different fungal strains
were screened based on their potential to produce
DPP IV. Cultural and nutritional parameters such
as initial moisture content, substrate concentration,
and cultivation time for the DPP IV production
were determined by the conventional “one variable
at a time” approach, and the levels of the critical
parameters were further optimized by response
surface methodology (RSM) for dietary supplement.
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Materials and methods
Materials
Aspergillus awamori, Aspergillus aculeatus, Aspergillus
carbonarius,
Aspergillus
ficuum,
Aspergillus
foetidus, Aspergillus tubingensis, Penicillium
canescens, Penicillium carneolutescens, Penicillium
italicum, Penicillium varians, Penicillium rubrum,
and Penicillium solitum were provided from the
Department of Bioengineering Culture Collection
(Ege University, Turkey), and Rhizopus oryzae NRRL
395 and Rhizopus oryzae NRRL 2286 were used in
screening for their potential for DPP IV production.
All cultures were maintained on potato dextrose agar
slants at 4 °C.
Wheat bran was supplied from Altınbaşak
Un Anonim Şirketi (İzmir, Turkey), and corn
flour and wheat flour were supplied from Kitle
Pazarlama Anonim Şirketi (İzmir, Turkey). Gly-Pro
p-nitroanilide (G-0513; Sigma Chemical Co., USA)
was used as a substrate in DPP IV assay. All chemicals
were of analytical grade.
Inoculum and culture conditions
All of the tested Aspergillus, Penicillium, and
Rhizopus strains were grown on malt extract agar
at 28 °C for 7 days. The spores were suspended in
0.2% (v/v) Tween 80 solution. One milliliter of
spore suspension (107 conidiospores/mL, counted
with a Thoma cell counting chamber) was used to
inoculate 250-mL flasks containing 5.0 g of screening
medium, including wheat bran and 0.7% (NH4)2SO4,
0.2% KH2PO4, 0.1% MgSO4, 2.0% corn flour, and
4.0% glucose (by weight of wheat bran on dry basis),
adjusting the initial moisture of the medium to 55%
(w/w) with distilled water. Medium was sterilized at
121 °C for 20 min. Incubation was carried out at 28
°C in an incubator.
After screening for the production of DPP IV, the
selected fungi were grown at 28 °C in 250-mL flasks
containing 5.0 g of wheat bran medium containing
2.0% corn flour or 2.0% wheat flour (by weight of wheat
bran used on dry basis) as a substrate, and Vogel salt
solution (Na-citrate.2H2O, 2.5 g/L; KH2PO4, 5.0 g/L;
MgSO4.7H2O, 0.2 g/L; NH4NO3, 2.0 g/L; CaCl2.2H2O,
0.1 g/L) was used as the moisturizing liquid instead
of distilled water. After sterilization at 121 °C for
20 min, the initial moisture of the medium was 55
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% (w/w). The levels of the critical parameters were
further optimized with the same medium mentioned
above.

graphical and numerical analysis using the Design
Expert program, based on the criterion of desirability.

Determination of initial moisture content

Results and discussion

Initial moisture content was measured by drying a
preweighed amount of substrate in Mettler Toledo
halogen moisture analyzer equipment until it reached
a constant weight. Weight loss in the original sample
was recorded as mass of evaporated water (g) and
converted to percent moisture content (w/w).
DPP IV assay
DPP IV was extracted by adding 25 mL of 0.2%
(v/v) Tween 80 solution to each flask containing the
fermented medium at 25 °C. Samples were mixed
with a glass rod for 10-min intervals and 30 min
of contact time was found to be sufficient for the
extraction process. After extraction, the mixture was
filtered through muslin cloth and centrifuged (10,000
rpm, 10 min, 4 °C). The supernatants were assayed
for DPP IV activity.
DPP IV assay was performed according to Sigma’s
quality control procedure (34). The reaction mixture
was prepared with 100 µL of supernatants and 100
µL of 1 mM Gly-Pro p-nitroanilide as a substrate
solution in 96-well plates. It was incubated for 15
min at 37 °C. DPP IV activity was assayed at 405
nm by measuring the degree of substrate hydrolysis
and comparing it with the p-nitroaniline (N-2128,
Sigma Chemical Co.) concentration curve. A unit
of enzyme activity was defined as the amount of the
enzyme (Unit) producing 1 µmol p-nitroaniline/min.
Results are expressed as mU/mL crude extract.
Experimental design
Design Expert (version 7.1.6, Stat-Ease, Inc., USA)
software was used for regression and graphical
analysis of the data obtained. The statistical analysis
of the model was performed in the form of analysis
of variance (ANOVA). The statistical significance
of the regression coefficients was determined by
Student’s t-test, the second order model equation was
determined by Fisher’s test, and the proportion of
variance explained by the model obtained was given
by the multiple coefficient of determination, R2. The
optimum values of the variables were obtained by

Aspergillus oryzae, Aspergillus fumigates, Aspergillus
niger, and Aspergillus nidulans were reported to
possess mRNA expression of DPP IV (30-33). In our
study, not only Aspergillus strains but also Penicillium
and Rhizopus strains were investigated for their DPP
IV production performance, since they are mentioned
in some patented productions (22,35). Figures 1 and
2 indicate the time course of DPP IV production by
Aspergillus and Penicillium strains. The maximum
DPP IV activities obtained from Rhizopus oryzae
NRRL 395 and Rhizopus oryzae NRRL 2280 were 59
mU/mL and 48 mU/mL, respectively, for 2 days of
cultivation.
All tested fungal strains indicated the ability to
produce DPP IV. Among them, Aspergillus awamori
T116 and Penicillium solitum CD120 were selected
for further experiments since they presented the
highest DPP IV activities.
Selected strains were further tested on wheat
flour-supplemented and corn flour-supplemented
medium with Vogel’s salts. The results are given in
Table 1.
It was observed that Aspergillus awamori T116
showed higher DPP IV activity in corn floursupplemented medium. Therefore, it was used in the
RSM experiments. Experimental set-up procedures
were planned to obtain a quadratic model consisting
of 23 trials plus 6 star points and 3 replicates at the
center point. The coded values of the independent
variables, namely corn flour in % (X1), initial moisture
content in % (X2), and cultivation time in days (X3),
and the experimental results of DPP IV activity in
mU/mL for each case are presented in Table 2.
The regression analysis showed that the model
can be expressed by Eq. (1), where the variables are in
the form of coded values. Here, the model represents
DPP IV activity (Y) as a function of corn flour (X1),
initial moisture content (X2), and cultivation time
(X3).

Y = 444.55 + 3.36X1 + 21.13X2 + 69.06X3 + 30.50 X1 X2 – 29.60 X1 X3 + 1.01 X2 X3 + 6.07 X12 – 31.41 X22 – 106.13 X32 (1)
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Figure 1. Production of DPP IV from Aspergillus awamori T116
(♦), Aspergillus tubingensis (●), Aspergillus aculeatus
(○), Aspergillus ficuum (Δ), and Aspergillus carbonarius
(□).
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Figure 2. Production of DPP IV from Penicillium solitum CD120
(▲), Penicillium canescens T93 (♦), Penicillium varians
T58 (□), Penicillium italicum R224 (●), Penicillium
carneolutescens 252 (○), Penicillium rubrum R246 (Δ),
and Penicillium lanosum R63 (■).

Table 1. Maximum DPP IV activities obtained in wheat flour-supplemented and corn
flour-supplemented medium by Aspergillus awamori T116 and Penicillium
solitum CD120.
Microbial source

Medium

DPP IV activity
(mU/mL)

Wheat flour

349.2
(4 days)

Corn flour

415.9
(4 days)

Wheat flour

42.0
(1 day)

Corn flour

29.4
(1 day)

Aspergillus awamori T116

Penicillium solitum CD120

The model F-value was found to be 16.16, implying
that the model was significant. The model F-value was
calculated as the ratio of the mean square regression
to the mean square residual. Thus, there was only a
0.07% chance that this “model F-value” occurs due
to noise. Values of “Prob>F” being less than 0.0500
indicates that the model terms are significant. In
this case, the model obtained was highly significant
with 3 significant terms of X3, X22, and X32, indicating
that the linear or direct effect of cultivation time
and quadratic effects of initial moisture content and
cultivation time are a function of DPP IV activity.
The determination coefficient (R2) for the model was
found to be 0.9541, indicating that only 4.59% of the
total variations could not be explained by the model.
The regression equation was represented by the 3D
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response surface graphics. The 3D response surfaces
are presented in Figures 3-5, from which the DPP IV
activity for different values of the variables can be
predicted.
In the bioprocess yielding the maximum activity
of DPP IV, initial moisture content and cultivation
time are important variables because they both,
individually and interactively, influence the response
considerably. By solving the model equation, the
optimal values of the test variables were found to
be: U1 (amount of corn flour) = 2.44% (w/w), U2
(initial moisture content) = 60.85% (w/w), and U3
(cultivation time) = 4.69 days with the corresponding
Y = 471.1 mU/mL. DPP IV activity was determined
as 462.6 mU/mL when optimized values were
applied. This result is obviously in close agreement
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Table 2. Experimental central composite design (CCD) runs in coded forms and corresponding responses.
Variables
X1
corn flour
(% w/w)

Runs

X2
initial moisture content
(% w/w)

Response
X3
cultivation time (days)

–1

–1

–1

197.04

1

–1

–1

185.13

3

–1

1

–1

191.56

4

1

1

–1

342.86

5

–1

–1

1

399.09

6

1

–1

1

309.98

7

–1

1

1

438.88

8

1

1

1

430.54

1
2

9

–1.682

0

0

462.23

10

1.682

0

0

464.61

11

0

–1.682

0

364.54

12

0

1.682

0

350.25

13

0

0

–1.682

62.42

14

0

0

1.682

229.68

15

0

0

0

429.83

16

0

0

0

447.93

17

0

0

0

455.32
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Figure 3. DPP IV activity as a function of initial moisture
content and cultivation time.
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Figure 4. DPP IV activity as a function of corn flour percentage
and cultivation time.
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480
452.5
425
397.5
370
65.95

4.39
62.97

3.95
60.00
57.03

B: Initial moisture content
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54.05 2.61
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3.50
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enzyme activity assays were applied in the literature.
However, in a comparable study performed by Monod
et al., it was mentioned that Aspergillus cells were
chosen according to their capability of producing at
least 100 mU/mL of DPP IV activity in submerged
culture where wheat gluten was used in a minimal
medium (35). Thus, according to these findings, it
can be concluded that promising enzyme titers were
obtained from this study.
Further studies will be conducted on purification
of the enzyme and the finding of the optimal dosage
in capsule form as a dietary supplement for autistics.

% (w/w)

Figure 5. DPP IV activity as a function of corn flour percentage
and initial moisture content.
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